The Effectiveness of Recombinant Human Erythropoietin (EPO) Treatment in a Neonate with Hyporegenerative Anemia Following Rh Isoimmunization in Spite of Normal Serum Epo Level

By Erduran Erol   Bahadir Aysenur  

Pediatric Hematology and Oncology, Vol. 28, Iss. 8, 2011-10 ,pp. : 721-722

Informa Healthcare

Access to resources Recommend Favorite

Safety of High-Dose Recombinant Erythropoietin in a Neonatal Rat Model

By  

Neonatology, Vol. 91, Iss. 1, 2006-11 ,pp. : 36-43

Karger

Access to resources Recommend Favorite

NO RESPONSE TO RECOMBINANT HUMAN ERYTHROPOIETIN THERAPY IN PATIENTS WITH CONGENITAL DYSERYTHROPOIETIC ANEMIA TYPE I

By Tamary Hannah   Tiqva Petah   Shalev Hanna   Pinsk Vered   Sheva Beer   Zoldan Meira   Zaizov Rina   Tiqva Petah  

Pediatric Hematology and Oncology, Vol. 16, Iss. 2, 1999-03 ,pp. : 165-168

Informa Healthcare

Access to resources Recommend Favorite

Recombinant Human Erythropoietin β: The Effect of Weekly Dosing on Anemia, Quality of Life, and Long-Term Outcomes in Pediatric Cancer Patients

By Durmaz Oguzhan   Demirkaya Metin   Sevinir Betül  

Pediatric Hematology and Oncology, Vol. 28, Iss. 6, 2011-08 ,pp. : 461-468

Informa Healthcare

Access to resources Recommend Favorite

Recombinant Human Erythropoietin Augments Angiogenic Responses in a Neonatal Rat Model of Cerebral Unilateral Hypoxia-Ischemia

By  

Neonatology, Vol. 106, Iss. 2, 2014-06 ,pp. : 143-148

Karger

Access to resources Recommend Favorite